-

Shareholder Alert: Robbins LLP Informs Investors that Astra Space, Inc. (ASTR) f/k/a Holicity Inc. (HOL) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of purchasers of Astra Space, Inc. (NASDAQ: ASTR) securities f/k/a Holicity Inc. (NASDAQ: HOL) between February 2, 2021 and December 29, 2021, for violations of the Securities Exchange Act of 1934. Astra Space purportedly operates as an operational space launch company.

If you suffered a loss due to Astra Space, Inc.'s misconduct, click here.

What is this Case About: Astra Space, Inc. (ASTR) Misled the Investing Public About its Business Prospects

According to the complaint, on June 30, 2021, Astra Space and Holicity Inc., a special purpose acquisition company, merged. During the class period, defendants touted the Company's ability to launch "anywhere in the world in 24 hours" and overstated the effectiveness and reliability of its designs, among other things.

On December 29, 2021, researcher Kerrisdale Capital released a report entitled "Astra Space, Inc. (ASTR): Headed for Dis-Astra," which alleged myriad issues with the Company. The report explained that Astra cannot launch from "anywhere in the world." In the U.S., for example, Astra can only launch from a FAA-licensed commercial spaceport approved for vertical launch. Further, the report indicated that Astra's forecast of 300 launches per year is highly speculative for many reasons, not the least of which is lack of market demand. The report noted that Astra has had only one successful orbital test flight and examined Astra's design failures. On this news, shares of Astra stock fell $1.10 per share, or approximately 14%, to close at $6.61 per share on December 29, 2021.

Next Steps: If you purchased shares of Astra Space, Inc. (ASTR) between February 2, 2021 and December 29, 2021, you have until April 11, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Astra Space, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:ASTR

Release Summary
Astra Space, Inc. (ASTR) Misled the Investing Public About its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the SES AI Corporation Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”)...

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...
Back to Newsroom